---
title: "Longshenrongfa Pharmaceutical Industry: Currently no relevant business and expansion plans in the brain-computer interface field"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253373375.md"
description: "On August 18th, Longshenrongfa Pharmaceutical Industry stated on the interactive platform that the company focuses on the research, production, and sales of traditional Chinese medicine, and currently has no related business or expansion plans in the field of brain-machine interfaces"
datetime: "2025-08-18T01:13:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253373375.md)
  - [en](https://longbridge.com/en/news/253373375.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253373375.md)
generator: "portal-rs"
---

# Longshenrongfa Pharmaceutical Industry: Currently no relevant business and expansion plans in the brain-computer interface field

On August 18th, Longshenrongfa Pharmaceutical Industry stated on the interactive platform that the company focuses on the research, production, and sales of traditional Chinese medicine, and currently has no related business or expansion plans in the field of brain-machine interfaces

### Related Stocks

- [300534.CN](https://longbridge.com/en/quote/300534.CN.md)

## Related News & Research

- [SF Holding Reports Solid First Half 2026 Results, Accelerating International Growth and Enhancing Shareholder Returns](https://longbridge.com/en/news/297341511.md)
- [BYD flash charging network to hit 10,000 stations on August 28, doubling in 5 months](https://longbridge.com/en/news/297123928.md)
- [12:56 ETUNice Hair Makes Its Case as One of the Best Human Hair Wig Brands in 2026](https://longbridge.com/en/news/297355307.md)
- [Endovia Health opens FDA INAD file for CannEpil veterinary program](https://longbridge.com/en/news/296915045.md)
- [BKW buys Germany’s Priedemann Fassadenberatung to expand engineering business](https://longbridge.com/en/news/297154729.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**